ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Researchers improve technology to save sperm stem cells – Medical Xpress

Continue reading

2017-04-07 Michael Zand NEWS

Scientists announce breakthrough in stem cell research – UPI.com


Medical Xpress

Researchers improve technology to save sperm stem cells
Medical Xpress
“If you’re a stem cell that is going to give rise to sperm essentially through the whole lifetime of an individual, you want to have a pristine genome,” said Oatley. “You don’t want it damaged by reactive oxygen species. That’s why we think glycolysis …

Continue reading

2017-04-07 Michael Zand NEWS

After Recent Developments Trading in US Stem Cell Inc (OTCMKTS:USRM) Increased Momentum – Street Register


UPI.com

Scientists announce breakthrough in stem cell research
UPI.com
April 6 (UPI) — Scientists have already successfully developed pluripotent stem cells in the lab, cells which can form any type of tissue. Totipotent stem cells are the pinnacle for stem cell scientists, however. And for the first time, researchers …
First Clinic-Ready Stem Cell RepositoryThe Scientist
NHLBI stem cell consortium provides new insights into genetics of heart disease, other conditionsNational Institutes of Health (press release)
Can Stem Cell ‘Patch’ Help Heart Failure?Everyday Health (blog)
Phys.Org –Engadget –Medical Xpress
all 69 news articles »
Continue reading

2017-04-07 Michael Zand NEWS

Stem Cell Treatment Might Reverse Symptoms Of Multiple Sclerosis … – CBS New York


Street Register

After Recent Developments Trading in US Stem Cell Inc (OTCMKTS:USRM) Increased Momentum
Street Register
US Stem Cell Inc (OTCMKTS:USRM) shares have been up significantly recently, and the rise could continue. The stock was up over 300% in a one month period recently, However, it looks like that recent meteoric rise could continue. If you’ve been …

and more »

Continue reading

2017-04-07 Michael Zand NEWS

HNSCC: Intratumoral Injection of T4 Immunotherapy Bypasses Homing – MedPage Today

HNSCC: Intratumoral Injection of T4 Immunotherapy Bypasses HomingMedPage TodayWASHINGTON — An intratumoral T4-immunotherapy with no preconditioning was safely administered to patients with advanced head and neck squamous cells carcinoma (HNSCC) at the… Continue reading

2017-04-06 Michael Zand NEWS

NORTH AMERICA STEM CELL ASSAY MARKET FORECAST 2017-2025 – PR Newswire (press release)

NORTH AMERICA STEM CELL ASSAY MARKET FORECAST 2017-2025PR Newswire (press release)The North America stem cell assay market is expected to grow $1082 million by 2025. The market growth is expected at the CAGR of 21.69% in the forecast period. The base y… Continue reading

2017-04-06 Michael Zand NEWS

Dr. Papa on CAR T-Cell Therapy for Head and Neck Cancer – OncLive

OncLiveDr. Papa on CAR T-Cell Therapy for Head and Neck CancerOncLiveCAR T-cell therapy has become a standard of care for patients with hematologic cancers, explains Papa. It is now attempting to be used for patients with head and neck cancer. Head and… Continue reading

2017-04-06 Michael Zand NEWS

Future of Immunotherapy Use in Lung Cancer – OncLive


CBS New York

Stem Cell Treatment Might Reverse Symptoms Of Multiple Sclerosis …
CBS New York
There’s potentially exciting news for the two and a half million people around the world struggling with multiple sclerosis.

and more »

Continue reading

2017-04-06 Michael Zand NEWS
  • 1
  • …
  • 1,873
  • 1,874
  • 1,875
  • 1,876
  • 1,877
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Future of Immunotherapy Use in Lung Cancer
OncLive
Benjamin P. Levy, MD: We’ve come quite a ways, in the past few years, with single agent immunotherapy. And now, the next horizon, and the next frontier, is what I call I-O (immuno-oncology), or “immunotherapy combination mania,” or “combo mania.”